DuPont’s recovery gains speed with another catalyst for stock looming

DuPont on Wednesday reported another beat-and-raise quarter, continuing a recovery partly driven by growing demand for AI chips — and rewarding our patience with the stock. Net sales in the three months ended June 30 totaled $3.17 billion, topping the $3.05 billion estimate, according to LSEG. Sales rose 2.5%...

Read more...

AMD jumps on earnings report that validates our decision to reinvest in the stock

Advanced Micro Devices on Tuesday proved it is an emerging force in the AI chip race, as its data center business helped fuel better-than-expected quarterly results. Revenue in the three months ended June 29 advanced 9% year over year to $5.84 billion, topping estimates of $5.72 billion, according to...

Read more...

Eli Lilly (LLY) says it can overcome high-quality problem of too much demand

Eli Lilly 's raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little doubt that the long-term Eli Lilly success story remains intact, as demand for its new diabetes and obesity drugs, Mounjaro and Zepbound, outstrips supply. Revenue...

Read more...